Poor response to initial reduction therapy (COP) and combined bone marrow and CNS disease are poor prognostic factors in children with advanced (BM +/- CNS) B-NHL treated on the international study FAB/LMB96.
Year: 2003
Type: article
Source: Blood
Authors: Cairo, Mary Gerrard, Richard Sposto, A. Aupérin, Ross Pinkerton, Jean Michon, Sara Perkins, Michael J. Raphael, Katie McCarthy, Claire Weston, Catherine Patte
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2521897900